BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Non Operating Income data on file, last reported at $14.5 million in Q1 2026.

• Quarterly Other Non Operating Income rose 268.0% year-over-year to $14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$32.0 million (down 205.9% YoY) and the FY2025 annual result came in at -$42.6 million, down 236.71% from the prior year.
• Other Non Operating Income grew to $14.5 million in Q1 2026 per ONC's latest filing, from -$35.7 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $336.7 million in Q3 2023 and bottomed at -$129.6 million in Q2 2022.
• The 5-year median for Other Non Operating Income is $4.0 million (2025), against an average of $2.6 million.
• Peak annual rise in Other Non Operating Income reached 390.25% in 2022, while the deepest fall reached 14850.06% in 2022.
• Tracing ONC's Other Non Operating Income over 5 years: stood at $19.4 million in 2022, then slipped by 13.83% to $16.7 million in 2023, then plunged by 182.0% to -$13.7 million in 2024, then sank by 159.87% to -$35.7 million in 2025, then jumped by 140.73% to $14.5 million in 2026.
• Per Business Quant, the three latest ONC Other Non Operating Income figures stand at $14.5 million (Q1 2026), -$35.7 million (Q4 2025), and -$19.0 million (Q3 2025).

Peer Comparison